Trisomy 21 and other chromosomal abnormalities in acute promyelocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 140, Issue 2, 2003, Pages 170-173

  Wan, T S K ^a   Ma, S K ^a   Au, W Y ^b   Liu, H S Y ^c   Chan, J C W ^c   Chan, L C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; RETINOIC ACID;

ADOLESCENT; ADULT; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIPLOIDY; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; SCHOOL CHILD; TRISOMY 12; TRISOMY 21; TRISOMY 8;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 21; DEATH, SUDDEN; FATAL OUTCOME; FEMALE; HONG KONG; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PULMONARY EMBOLISM; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSLOCATION, GENETIC; TRETINOIN; TRISOMY;

EID: 0037438881     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00684-2     Document Type: Article

References (15)

1. Spell D.W., Velagaleti G.V.N., Jones D.V., Velasquez W.S. Translocation (15;17) and trisomy 21 in the microgranular variant of acute promyelocytic leukemia. Cancer Genet Cytogenet. 132:2002;74-76.
2. Wan T.S.K., Au W.Y., Chan J.C.W., Chan L.C., Ma S.K. Trisomy 21 as the sole acquired karyotypic abnormality in acute myeloid leukemia and myelodysplastic syndrome. Leuk Res. 23:1999;1079-1083.
3. Berger R., Le Coniat M., Derré J., Vecchione D., Jonveaux P. Cytogenetic studies in acute promyelocytic leukemia. A survey of secondary chromosomal abnormalities Genes Chromosomes Cancer. 3:1991;332-337.
4. Xu L., Zhao W.L., Xiong S.M., Su X.Y., Zhao M., Wang C., Gao Y.R., Niu C., Cao Q., Gu B.W., Zhu Y.M., Gu J., Hu J., Yan H., Shen Z.X., Chen Z., Chen S.J. Molecular cytogenetic characterization and clinical relevance of additional, complex and/or variant chromosome abnormalities in acute promyelocytic leukemia. Leukemia. 15:2001;1359-1368.
5. Zimonjic D.B., Pollock J.L., Westervelt P., Popescu N.C., Ley T.J. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice. Proc Natl Acad Sci USA. 97:2000;13306-13311.
6. de Botton S., Chevret S., Sanz M., Dombret H., Thomas X., Guerci A., Fey M., Rayon C., Huguet F., Sotto J., Gardin C., Makhoul P.C., Travade P., Solary E., Fegueux N., Bordessoule D., San Miguel J., Link H., Desablens B., Stamatollas A., Deconinck E., Geiser K., Hess U., Maloisel F., Castaigne S., Preudhomme C., Chomienne C., Degos L., Fenaux P., for the European A.P.L., Group Additional chromosomal abnormalities in patients with acute promyelocytic leukemia (APL) do not confer poor prognosis. results of APL 93 trial Br J Haematol. 111:2000;801-806.
7. Kwong Y.L., Wong K.F., Chan T.K. Trisomy 8 in acute promyelocytic leukaemia. an interphase study by fluorescence in situ hybridization Br J Haematol. 90:1995;697-700.
8. Schoch C., Haase D., Haferlach T., Freund M., Link H., Lengfelder E., Loffler H., Buchner T., Fonatsch C. Incidence and implication of additional chromosome aberrations in acute promyelocytic leukemia with translocation t(15;17)(q22;q21). a report on 50 patients Br J Haematol. 94:1996;493-500.
9. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., Rees J., Hann I., Stevens R., Burnett A., Goldstone A. The importance of diagnostic cytogenetics on outcome in AML. Analysis of 1,612 patients entered into the MRC AML 10 trial Blood. 92:1998;2322-2333.
10. Hirons L.R., Swansbury G.J., Mehta J., Min T., Dainton M.G., Treleaven J., Powles R.L., Catovsky D. Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukemia. Br J Haematol. 96:1997;314-321.
11. Pantic M., Novak A., Marisavlijevic D., Djordjevic V., Elezovic I., Vidovic A., Colovic M. Additional chromosome aberrations in acute promyelocytic leukemia. characteristics and prognostic influence Med Oncol. 17:2000;307-313.
12. Slack J.L., Arthur D.C., Lawrence D., Mrózek K., Mayer R.J., Davey F.R., Tantravahi R., Pettenati M.J., Bigner S., Carroll A.J., Rao K.W., Schiffer C.A., Bloomfield C.D. Secondary cytogenetic changes in acute promyelocytic leukemia- Prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene. a Cancer and Leukemia Group B study J Clin Oncol. 15:1997;1786-1795.
13. Au W.Y., Ma S.K., Lam C.C., Chan L.C., Kwong Y.L. Tetraploid acute promyelocytic leukemia with large bizarre blast cell morphology. Cancer Genet Cytogenet. 115:1999;52-55.
14. Wan T.S.K., Chim C.S., So C.K., Chan L.C., Ma S.K. Complex variant 15;17 translocations in acute promyelocytic leukemia. a case report and review of three-way translocation Cancer Genet Cytogenet. 111:1999;139-143.
15. Chim C.S., Lam C.C.K., Wong K.F., Man C., Kam S., Kwong Y.L. Atypical blasts and bone marrow necrosis associated with near-triploid relapse of acute promyelocytic leukemia after arsenic trioxide treatment. Human Pathol. 33:2002;849-851.